Ruveyda Ayasun

8PUBLICATIONS
65CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 14, 2026
ACKR3 Establishes a Squamous-Restricted Immune Checkpoint Axis in Lung Squamous Cell Carcinoma.

|Nov 09, 2024
Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis.

Taha Koray Sahin, Ruveyda Ayasun, Alessandro Rizzo

|May 13, 2024
Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine.

Ibrahim Halil Sahin, Turcin Saridogan, Ruveyda Ayasun

|Jul 24, 2023
A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer.

Justine Habault, Jeffrey A Schneider, Susan Ha

|May 13, 2023
The Role of HER2 Status in the Biliary Tract Cancers.

Ruveyda Ayasun, Muhammet Ozer, Ilyas Sahin

|Jun 06, 2022
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis.

William Damsky, Alice Wang, Daniel J Kim

Pageof 2

Frequent Collaborators

2 joint publications

Deniz Can Guven

2 joint publications

Kwok-Kin Wong

2 joint publications

Dafna Bar-Sagi

1 joint publications

Emre Yekedüz